Skip to content
OpenCapital
Get started

Phibro Animal Health PAHC EBITDA

EBITDA at other companies

Neogen logo
NeogenNEOG
$25.62M-26.3%
Balchem logo
BalchemBCPC
$68.12M+9.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$782.59M-8,471%
Merck & Co. logo
Merck & Co.MRK
——
Zoetis logo
ZoetisZTS
——
Amgen logo
AmgenAMGN
——

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
Enterprise value$1.25B+33.9%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

$44.7Mebit+
$12.4MDepreciation Depletion & Amortization
=$57.1M

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's EBITDA?
Phibro Animal Health (PAHC) reported EBITDA of $57.1M in Q1 2026.
How has Phibro Animal Health's EBITDA changed year-over-year?
Phibro Animal Health's EBITDA increased by 23.8% year-over-year, from $46.13M to $57.1M.
What is the long-term trend for Phibro Animal Health's EBITDA?
Over 4 years (2021 to 2025), Phibro Animal Health's EBITDA has grown at a 10.0% compound annual growth rate (CAGR), from $106.75M to $156.07M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.